Some skincare brands trend for a season, and others quietly become staples in bathrooms around the world. La Roche-Posay is the latter — a brand that transcends trends, algorithms, and hype. Its ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

Roche reported positive Phase III results on trials of its new multiple sclerosis (MS) drug today. Fenebrutinib appears effective at treating both relapsing multiple sclerosis and primary progressive ...

Wondering if Roche Holding might be a hidden gem in today’s market? You’re not alone, as many investors are taking a closer look at what makes this pharmaceutical giant’s stock interesting right now.

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the booming market for weight-loss medicines. The drug, known as CT-388, ...

Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...

If you click on links we provide, we may receive compensation. One shopper even called it the “holy grail for moisture” Alyssa Grabinski is a senior shopping writer for PEOPLE reporting on can’t-miss ...

Navigating adult breakouts while simultaneously trying to tackle the first signs of ageing is a journey. One day it's a new blemish popping up, the next it's a concern about skin texture or firmness.

Summertime can be hellish for those of us with oily skin, so I’m always on the hunt for brands that aim to reduce oil production without overdrying my skin. La Roche-Posay is one of them. The brand’s ...

New Creative NZ chief executive Gretchen La Roche after the pōwhiri held to welcome her into the role. Photo / Creative New Zealand From working at her auntie’s Aberdeen Rd dairy to leading our ...